A 62-year-old man is admitted to the orthopedic unit following a total hip arthroplasty. On postoperative day 2, he develops sudden-onset chest pain, tachycardia, and dyspnea. The cross-covering physician evaluates the patient and suspects an acute pulmonary embolism. The physician orders a therapeutic dose of intravenous enoxaparin. The patient's electronic medical record contains a clearly documented severe allergy to heparin, specifically noting a history of heparin-induced thrombocytopenia. When the physician places the order, a computerized physician order entry (CPOE) alert is generated. However, the physician overrides the alert, assuming it is a generic, low-priority warning, as the system frequently flags non-critical drug interactions. The nurse administers the medication. Over the next 24 hours, the patient develops severe thrombocytopenia and a new deep vein thrombosis. The patient is transferred to the intensive care unit, stabilized with a non-heparin anticoagulant, and the error is disclosed to the patient and his family. Which of the following is the most appropriate next step in the institutional review of this adverse event?
- Convene a multidisciplinary committee to perform a root cause analysis of the system vulnerabilitiesCevap
- BConduct a failure mode and effects analysis to prospectively evaluate the computerized order entry system
- CConclude the investigation immediately because the physician's failure to read the alert is the definitive cause of the error
- DReport the physician to the state medical board for a mandatory review of clinical competence
- ERestrict the investigation to standardizing the shift handoff communication between the primary and cross-covering teams